Clinical Trial Update: Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of bempedoic acid (ETC-1002) in hyperlipidemia patients intolerant to statins; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia, Atherosclerotic Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-04-03